Jefferies analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and lowers the price target from $105 to $85.
Telsey Advisory Group Maintains Outperform on Nike, Raises Price Target to $190
Telsey Advisory Group analyst Joseph Feldman maintains Nike (NYSE:NKE) with a Outperform and raises the price target from $176 to $190.